3 Chopt Investment Partners, LLC Abbott Laboratories Transaction History

3 Chopt Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 21, 2024	BUY	$100.73 - $112.44 $759,302 - $847,572	7,538 New	7,538 $783 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $436,790 - $534,667	4,843 New	4,843 $533 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $20,055 - $22,345	-199 Reduced 4.59%	4,139 $451 Million
Q1 2023 May 22, 2023	BUY	$96.86 - $114.01 $420,178 - $494,575	4,338 New	4,338 $439 Million
Q4 2022 May 24, 2023	SELL	$95.06 - $111.52 $25,381 - $29,775	-267 Reduced 6.15%	4,071 $447 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of 3 Chopt Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on 3 Chopt Investment Partners, LLC with notifications on news.